486 results on '"Mactutus, Charles F."'
Search Results
2. Adolescent oral oxycodone self-administration disrupts neurobehavioral and neurocognitive development
3. SARS-CoV-2 RNA persists in the central nervous system of non-human primates despite clinical recovery
4. Microglia proliferation underlies synaptic dysfunction in the prefrontal cortex: implications for the pathogenesis of HIV-1-associated neurocognitive and affective alterations
5. Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations
6. Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
7. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History
8. S-Equol mitigates motivational deficits and dysregulation associated with HIV-1
9. S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV
10. Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
11. HIV-1 mRNA Knockdown with CRISPR/Cas9 Enhances Neurocognitive Function
12. Diagnostic and prognostic biomarkers for HAND
13. Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure
14. SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery
15. Constitutive expression of HIV-1 viral proteins induces progressive synaptodendritic alterations in medium spiny neurons: implications for substance use disorders
16. Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders
17. Microglia Proliferation Underlies Synaptic Dysfunction in the Prefrontal Cortex: Implications for the Pathogenesis of HIV-1-Associated Neurocognitive and Affective Alterations
18. Correction to: HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History
19. A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat
20. Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1
21. Synaptic dysfunction is associated with alterations in the initiation of goal-directed behaviors: Implications for HIV-1-associated apathy
22. HIV-1 proteins dysregulate motivational processes and dopamine circuitry
23. Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent Rats
24. Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain
25. Motivational Dysregulation with Melanocortin 4 Receptor Haploinsufficiency
26. HIV-1 Tat protein variants: Critical role for the cysteine region in synaptodendritic injury
27. Disrupted Decision-Making: EcoHIV Inoculation Following a History of Cocaine Use
28. HIV-1 Transgenic Female Rat: Synaptodendritic Alterations of Medium Spiny Neurons in the Nucleus Accumbens
29. Modeling Deficits in Attention, Inhibition, and Flexibility in HAND
30. Neurodevelopmental Processes in the Prefrontal Cortex Derailed by Chronic HIV-1 Viral Protein Exposure
31. SYNAPTIC DYSFUNCTION UNDERLIES ALTERATIONS IN THE INITIATION OF GOAL-DIRECTED BEHAVIORS: IMPLICATIONS FOR HIV-1 ASSOCIATED APATHY
32. Neurodevelopmental processes in the prefrontal cortex derailed by chronic HIV-1 viral protein exposure
33. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons
34. Time and Time Again: Temporal Processing Demands Implicate Perceptual and Gating Deficits in the HIV-1 Transgenic Rat
35. HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits
36. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS
37. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons
38. Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat
39. Synaptodendritic recovery following HIV Tat exposure: Neurorestoration by phytoestrogens
40. Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders
41. Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains
42. Animal Models: Behavior and Pathology: Preclinical Assessment of the Putative Cognitive Deficits in HAND
43. Neurotoxicity of HIV-1 Tat protein: Involvement of D1 dopamine receptor
44. Neonatal intrahippocampal gp120 injection: An examination early in development
45. A Rat Model of EcoHIV Brain Infection
46. Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
47. HIV-1-induced apathy: Mitigation by the gut metabolite, S-Equol
48. A Hydrophobic Tissue Clearing Method for Rat Brain Tissue
49. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: The role of oxidative stress and D1 dopamine receptor
50. Adolescent HIV-1 Transgenic Rats: Evidence for Dopaminergic Alterations in Behavior and Neurochemistry Revealed by Methamphetamine Challenge
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.